Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

Related Articles by Review for PubMed (Select 18936575)

1.

Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.

Chapman WC, Majella Doyle MB, Stuart JE, Vachharajani N, Crippin JS, Anderson CD, Lowell JA, Shenoy S, Darcy MD, Brown DB.

Ann Surg. 2008 Oct;248(4):617-25. doi: 10.1097/SLA.0b013e31818a07d4.

PMID:
18936575
2.

Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis.

Lesurtel M, Müllhaupt B, Pestalozzi BC, Pfammatter T, Clavien PA.

Am J Transplant. 2006 Nov;6(11):2644-50. Epub 2006 Aug 25. Review.

3.

Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis.

Koschny R, Schmidt J, Ganten TM.

Clin Transplant. 2009 Dec;23 Suppl 21:49-60. doi: 10.1111/j.1399-0012.2009.01110.x. Review.

PMID:
19930317
4.

Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma.

Chua TC, Liauw W, Saxena A, Chu F, Glenn D, Chai A, Morris DL.

Liver Int. 2010 Feb;30(2):166-74. doi: 10.1111/j.1478-3231.2009.02166.x. Epub 2009 Nov 13. Review.

PMID:
19912531
5.

Chemoembolization of hepatocellular carcinoma.

Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF.

J Vasc Interv Radiol. 2002 Sep;13(9 Pt 2):S211-21. Review.

PMID:
12354839
6.

Treatment before liver transplantation for HCC.

Belghiti J, Carr BI, Greig PD, Lencioni R, Poon RT.

Ann Surg Oncol. 2008 Apr;15(4):993-1000. doi: 10.1245/s10434-007-9787-8. Epub 2008 Jan 31. Review.

PMID:
18236111
7.

Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.

Gordon-Weeks AN, Snaith A, Petrinic T, Friend PJ, Burls A, Silva MA.

Br J Surg. 2011 Sep;98(9):1201-8. doi: 10.1002/bjs.7561. Epub 2011 May 27. Review.

PMID:
21618496
8.

Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation.

Pompili M, Francica G, Ponziani FR, Iezzi R, Avolio AW.

World J Gastroenterol. 2013 Nov 21;19(43):7515-30. doi: 10.3748/wjg.v19.i43.7515. Review.

9.

Management of hepatocellular carcinoma.

Said A, Wells J.

Minerva Med. 2009 Feb;100(1):51-68. Review.

PMID:
19277004
10.

Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?

Biolato M, Marrone G, Racco S, Di Stasi C, Miele L, Gasbarrini G, Landolfi R, Grieco A.

Eur Rev Med Pharmacol Sci. 2010 Apr;14(4):356-62. Review.

PMID:
20496548
11.

Section 3. Current status of downstaging of hepatocellular carcinoma before liver transplantation.

Sharr WW, Chan SC, Lo CM.

Transplantation. 2014 Apr 27;97 Suppl 8:S10-7. doi: 10.1097/01.tp.0000446267.19148.21. Review.

PMID:
24849822
12.

Hepatocellular carcinoma: interventional bridging to liver transplantation.

Lubienski A.

Transplantation. 2005 Sep 27;80(1 Suppl):S113-9. Review.

PMID:
16286887
13.

Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications.

Vogl TJ, Naguib NN, Nour-Eldin NE, Rao P, Emami AH, Zangos S, Nabil M, Abdelkader A.

Eur J Radiol. 2009 Dec;72(3):505-16. doi: 10.1016/j.ejrad.2008.08.007. Epub 2008 Oct 2. Review.

PMID:
18835117
14.

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

Raoul JL, Sangro B, Forner A, Mazzaferro V, Piscaglia F, Bolondi L, Lencioni R.

Cancer Treat Rev. 2011 May;37(3):212-20. doi: 10.1016/j.ctrv.2010.07.006. Epub 2010 Aug 17. Review.

PMID:
20724077
15.

Current treatment strategy for hepatocellular carcinoma.

Ng KK, Poon RT.

Saudi Med J. 2007 Sep;28(9):1330-8. Review.

PMID:
17768455
16.

Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate.

Cescon M, Cucchetti A, Ravaioli M, Pinna AD.

J Hepatol. 2013 Mar;58(3):609-18. doi: 10.1016/j.jhep.2012.09.021. Epub 2012 Oct 4. Review.

17.

Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria.

Yao FY.

Am J Transplant. 2008 Oct;8(10):1982-9. doi: 10.1111/j.1600-6143.2008.02351.x. Epub 2008 Aug 22. Review.

18.

Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.

Zimmerman MA, Ghobrial RM, Tong MJ, Hiatt JR, Cameron AM, Hong J, Busuttil RW.

Arch Surg. 2008 Feb;143(2):182-8; discussion 188. doi: 10.1001/archsurg.2007.39. Review.

PMID:
18283144
19.

Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?

Roayaie K, Feng S.

Liver Transpl. 2007 Nov;13(11 Suppl 2):S36-43. Review.

20.

Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.

Tsochatzis EA, Germani G, Burroughs AK.

Semin Oncol. 2010 Apr;37(2):89-93. doi: 10.1053/j.seminoncol.2010.03.007. Review.

PMID:
20494700
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk